OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: a bioinformatic analysis combine with RNAi and oligonucleotide microarray

Oncol Rep. 2015 Apr;33(4):1965-75. doi: 10.3892/or.2015.3792. Epub 2015 Feb 10.

Abstract

Given its tumor-specific expression, including liver cancer, OY-TES-1 is a potential molecular marker for the diagnosis and immunotherapy of liver cancers. However, investigations of the mechanisms and the role of OY-TES-1 in liver cancer are rare. In the present study, based on a comprehensive bioinformatic analysis combined with RNA interference (RNAi) and oligonucleotide microarray, we report for the first time that downregulation of OY-TES-1 resulted in significant changes in expression of NANOG, CD9, CCND2 and CDCA3 in the liver cancer cell line BEL-7404. NANOG, CD9, CCND2 and CDCA3 may be involved in cell proliferation, migration, invasion and apoptosis, yet also may be functionally related to each other and OY-TES-1. Among these molecules, we identified that NANOG, containing a Kazal-2 binding motif and homeobox, may be the most likely candidate protein interacting with OY-TES-1 in liver cancer. Thus, the present study may provide important information for further investigation of the roles of OY-TES-1 in liver cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs
  • Apoptosis
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / pathology
  • Carrier Proteins / chemistry
  • Carrier Proteins / genetics
  • Carrier Proteins / physiology*
  • Cell Adhesion
  • Cell Cycle Proteins / biosynthesis
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / physiology
  • Cell Division
  • Cell Movement
  • Computational Biology
  • Cyclin D2 / biosynthesis
  • Cyclin D2 / genetics
  • Cyclin D2 / physiology*
  • Databases, Genetic
  • Gene Expression Regulation, Neoplastic*
  • Homeodomain Proteins / biosynthesis
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / physiology*
  • Humans
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / pathology
  • Nanog Homeobox Protein
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / chemistry
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / physiology*
  • Oligonucleotide Array Sequence Analysis
  • Protein Interaction Mapping
  • Protein Structure, Tertiary
  • RNA, Bacterial
  • RNA, Messenger / biosynthesis
  • RNA, Neoplasm / biosynthesis
  • Tetraspanin 29 / biosynthesis
  • Tetraspanin 29 / genetics
  • Tetraspanin 29 / physiology*
  • Transcriptome

Substances

  • ACRBP protein, human
  • CCND2 protein, human
  • CD9 protein, human
  • CDCA3 protein, human
  • Carrier Proteins
  • Cell Cycle Proteins
  • Cyclin D2
  • Homeodomain Proteins
  • NANOG protein, human
  • Nanog Homeobox Protein
  • Neoplasm Proteins
  • RNA I
  • RNA, Bacterial
  • RNA, Messenger
  • RNA, Neoplasm
  • Tetraspanin 29